Selective disruption of GHR in adipose tissue increases adipose mass and decreases circulating adipsin, but does not affect adiponectin, resistin, or glucose metabolism.
Does selective disruption of GHR in adipose tissue alter adiposity, adipokine levels, and glucose metabolism in mice?
Adipose-specific GHR disruption in mice increases adiposity but does not replicate the improved glucose homeostasis or elevated adiponectin/resistin seen in global GHR knockout mice.
Tasa de eventos absoluta: 0% vs 0%
Abstract GH receptor (GHR) gene-disrupted mice (GHR−/−) have provided countless discoveries as to the numerous actions of GH. Many of these discoveries highlight the importance of GH in adipose tissue. For example GHR−/− mice are insulin sensitive yet obese with preferential enlargement of the sc adipose depot. GHR−/− mice also have elevated levels of leptin, resistin, and adiponectin, compared with controls leading some to suggest that GH may negatively regulate certain adipokines. To help clarify the role that GH exerts specifically on adipose tissue in vivo, we selectively disrupted GHR in adipose tissue to produce Fat GHRKnockout (FaGHRKO) mice. Surprisingly, FaGHRKOs shared only a few characteristics with global GHR−/− mice. Like the GHR−/− mice, FaGHRKO mice are obese with increased total body fat and increased adipocyte size. However, FaGHRKO mice have increases in all adipose depots with no improvements in measures of glucose homeostasis. Furthermore, resistin and adiponectin levels in FaGHRKO mice are similar to controls (or slightly decreased) unlike the increased levels found in GHR−/− mice, suggesting that GH does not regulate these adipokines directly in adipose tissue in vivo. Other features of FaGHRKO mice include decreased levels of adipsin, a near-normal GH/IGF-1 axis, and minimal changes to a large assortment of circulating factors that were measured such as IGF-binding proteins. In conclusion, specific removal of GHR in adipose tissue is sufficient to increase adipose tissue and decrease circulating adipsin. However, removal of GHR in adipose tissue alone is not sufficient to increase levels of resistin or adiponectin and does not alter glucose metabolism.
List et al. (Fri,) reported a other. Selective disruption of GHR in adipose tissue increases adipose mass and decreases circulating adipsin, but does not affect adiponectin, resistin, or glucose metabolism.